Clinical Trial Update: Food Effect and Multiple-Dose Study of Chiglitazar/Metformin Extended-Release Tablets [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating the effects of food on pharmacokinetics and the safety of multi-dose chiglitazar/metformin extended-release tablets in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Chiglitazar (Chiglitazar)
• Metformin Extended-Release Tablet (metformin extended-release)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 1 | Status: NOT_YET_RECRUITING